Lymphoma chemotherapy in Italy typically costs from $8,500 to $18,000. The final price depends on the drug regimen, clinic location, and treatment duration. In the US, similar procedures cost around $22,500 on average. Patients save around 41% compared to US prices. Inclusions often cover specialist consultations, diagnostic monitoring, and chemotherapy administration over a two-week period.
Bookimed Expert Insight: Choosing a research hospital like San Raffaele in Milan offers exceptional value. This facility holds IRCCS status from the Italian Ministry of Health. This means they combine active scientific research with daily medical assistance. Patients access cutting-edge protocols often unavailable in standard clinics. While Milan prices can be higher, the medical expertise is world-class. San Raffaele is even recognized by Newsweek among the world's best hospitals.
Why choose Italy for lymphoma chemotherapy?
Access advanced Lymphoma chemotherapy solutions in trusted clinics .
| Italy | Turkey | Austria | |
| Lymphoma chemotherapy | from $8,500 | from $3,000 | from $8,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Lymphoma chemotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lymphoma chemotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lymphoma chemotherapy journey.
Day 1
Day 2
Day 3-4
Day 5
Week 2-6
Week 7 onwards
Please note that the above timeline is a general guideline and individual cases may vary.
The doctor serves as the Deputy Director of the Hematology Oncology Department and Director of the Lymphoma Unit at the San Raffaele Scientific Institute, with a focus on lymphoma treatment.
He is the founder of the Italian Lymphoma Foundation, dedicated to advancing clinical studies in lymphoma management.
His academic background includes a degree in general medicine and surgery from the University of Buenos Aires and the University of Parma, and a specialty in medical oncology from the University of Milan.
The doctor has authored over 300 papers on lymphoma treatment and is a member of several prestigious hematology and oncology societies.